It also addresses the FDA’s communications Together with the applicant, the retention of records that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of the SE report to a fresh applicant and Digital submission of your SE report and amendments